Judy

The NeurologyLive TAPSA 2026 report underscores a pivotal shift in bioelectronic medicine, moving decisively from generic stimulation to personalized neuromodulation. This evolution, exemplified by devices like the kIQ Plus, tailors therapy to an individual’s unique neurophysiological signature for superior outcomes in conditions like tremor. It represents a fundamental rethinking of how medical devices interact with […]

Presented at the American Academy of Neurology 2026 Annual Meeting, data from Cala’s Poster P5-005 demonstrated that the kIQ system’s novel variable waveforms achieved significantly higher responder rates in treating essential tremor. This advancement represents a meaningful step in personalized neuromodulation, offering a more adaptable and potentially more effective therapy by dynamically adjusting stimulation patterns

Trinity Capital’s $50 million growth capital investment in Cala Health represents a pivotal vote of confidence in the future of non-invasive neuromodulation. This infusion will accelerate the commercial scale-up of Cala’s TAPS therapy, a wearable device designed to treat essential tremor, expanding patient access and driving next-generation innovation in a high-growth medical device segment. Medical

The FDA’s 510(k) clearance of the Cala kIQ Plus in April 2026 marks a significant advancement in non-invasive tremor management. This next-generation wearable features adaptive calibration and new therapy modes, offering a more personalized and effective treatment for patients with Essential Tremor (ET) and Parkinson’s Disease (PD) tremor. It represents a leap forward in accessible,

In February 2026, major North American health networks fully integrated Cala kIQ neuromodulation devices into cloud-based clinic procurement systems. This enables just-in-time (JIT) inventory management, allowing clinics to order wearables automatically as needed, cutting storage costs and ensuring patient access to tremor therapy. HHG GROUP highlights this as a supply chain game-changer. Medical Equipment Store

AI‑driven procurement software for healthcare providers is transforming how hospitals and clinics source medical technology, including advanced devices like the Cala kIQ system. Using predictive analytics, new platforms launched in Q1 2026 forecast when patients with Essential Tremor are most likely to need device upgrades, aligning purchases with clinical demand. This shift turns the Cala

Tracking hospital equipment utilization for neuromodulation devices such as Cala kIQ units improves ROI by identifying real usage patterns, reducing idle time, and supporting data-driven purchasing decisions. Clinics achieving up to 95% daily utilization can justify fleet expansion, optimize patient access, and lower operational costs while maximizing revenue from each device across the care continuum.

Cala Health’s expansion of OEM services is transforming neurotechnology by enabling companies to license its TAPS architecture for customized device development. This approach reduces development time, lowers costs, and promotes standardization across medical hardware. As adoption grows, it could enhance innovation, improve patient access to advanced therapies, and strengthen compatibility across the global healthcare ecosystem.

Yes, on April 16, 2026, the U.S. Food and Drug Administration granted 510(k) clearance for the Cala kIQ Plus, an updated wrist‑worn neurostimulation system for on‑demand tremor relief in Essential Tremor and Parkinson’s Disease. The device builds on TAPS Therapy with adaptive calibration and new therapy modes, offering greater precision, comfort, and clinical utility than

The wearable tremor therapy market has surpassed $870 million in 2026, fueled by rising neurological disorders, demand for non-drug treatments, and advances in wearable neuromodulation technology. These devices provide targeted, non-invasive relief for tremors, improving patient outcomes while reducing reliance on pharmaceuticals and supporting a broader shift toward electronic medicine in modern healthcare systems. Medical